Spinal degenerative diseases
Conditions
Interventions
Experimental group:For Caprini score moderate risk: IPC treatment twice daily, 1 hour per session. For Caprini score high risk: IPC treatment three times daily, 1 hour per session. For Caprini score v
Control group:For all patients with moderate, high, or very high Caprini risk: IPC twice daily, 30 minutes per session.
Sponsors
The Second Affiliated Hospital of the Army Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1.Age between 18 and 80 years, with complete clinical data; 2.Diagnosed with spinal disease and scheduled to undergo elective or emergency spinal surgery; 3.The Caprini thrombosis risk assessment score indicates a moderate-risk or higher level of risk; 4.Conscious, without severe cognitive or communication impairment, able to understand and cooperate with the study interventions and assessments; 5.Willing to participate voluntarily in this study and sign a written informed consent form.
Exclusion criteria
Exclusion criteria: 1. Diagnosed with lower extremity deep vein thrombosis (DVT) or pulmonary embolism (PE) by imaging examination upon admission; 2.Presence of active bleeding or high risk of bleeding (e.g., known severe coagulation disorders, active peptic ulcer, history of intracranial hemorrhage, etc.); 3.Severe peripheral arterial disease, or conditions of the lower limbs unsuitable for the use of intermittent pneumatic compression devices (e.g., dermatitis, infection, severe edema, open wounds, etc.); 4. Combined severe cardiac, hepatic, or renal insufficiency (as determined by the attending physician's clinical diagnosis); 5. Women who are pregnant or breastfeeding; 6. Concurrent participation in other clinical trials that may interfere with the outcomes of this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The peak flow velocities of blood flow in the common femoral vein and the popliteal vein; | — |
Secondary
| Measure | Time frame |
|---|---|
| The incidence rate of VTE;D-dimer concentration;Fibrinogen concentration;Platelet count; | — |
Countries
China
Contacts
Public ContactLuo Chunmei
The Second Affiliated Hospital of the Army Medical University
Outcome results
None listed